LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.”
AstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when dozens of countries suspended the vaccine’s use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca’s shot didn’t raise the overall risk of clots, but doubts remained.
Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge. Insufficient data about how well the vaccine protected older people led some countries to initially restrict its use to younger populations before reversing course.
Related articles:
Related suggestion:
Jones carries Xinjiang past Beijing in CBATsinghua art and science symposium explores future trends, presents awardsShenzhen, Zhejiang into last eight of CBA playoffsAncelotti calls for courage, personality vs. Man CityBeijing film fest unveils jury, film lineup and key highlightsMaui Fire Department to release afterFire rages through Copenhagen's historic stock exchange, spire collapsesArmenia insists top UN court has jurisdiction to hear case accusing Azerbaijan of racial hatredDisneyland rides on its swift successesAtletico dealt Depay injury blow for Dortmund clash
2.8132s , 6490.953125 kb
Copyright © 2024 Powered by AstraZeneca pulls COVID vaccine from European market ,Stellar Stance news portal